SCHEMBL7908162

SCHEMBL7908162

C=C(N)/C(C#N)=C/c1ccc(O)c(O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.71
DNM1 Q05193 8/20 0.71
KDM4E B2RXH2 7/20 0.71
MEN1 O00255 7/20 0.71
ALDH1A1 P00352 7/20 0.71
KMT2A Q03164 7/20 0.71
MAPT P10636 6/20 0.71
HPGD P15428 6/20 0.71
ERBB2 P04626 6/20 0.71
TDP1 Q9NUW8 5/20 0.71
BLM P54132 5/20 0.71
TP53 P04637 5/20 0.71
HSD17B10 Q99714 5/20 0.71
CYP1A2 P05177 4/20 0.71
RECQL P46063 4/20 0.71
PMP22 Q01453 4/20 0.71
CYP3A4 P08684 4/20 0.71
ALOX15 P16050 4/20 0.71
ALOX12 P18054 4/20 0.71
MAPK1 P28482 4/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13060220 0.86 EGFR (0.77) EGFRDNM1KDM4EMEN1ALDH1A1
SCHEMBL1705642 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
Tyrphostin 47 SCHEMBL5800282 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
SCHEMBL29357420 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
Tyrphostin 47 SCHEMBL1704818 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
SCHEMBL6285299 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
Tyrphostin 47 SCHEMBL5802738 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
Tyrphostin 47 SCHEMBL5802735 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
Tyrphostin 47 SCHEMBL29422960 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1
Tyrphostin 47 SCHEMBL29378969 0.83 EGFR (1.00) EGFRDNM1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012012278-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX CORNING INCORPORATED (US) 2012-01-26 WO disclosed
WO-2010048446-A2 MODULATION OF AXON DEGENERATION GENENTECH, INC. (US) 2010-04-29 WO disclosed